2-ethylbutyraldehyde | 39992-52-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-ethylbutyraldehyde
• 英文别名: 3-ethylpentanal
• CAS: 39992-52-4
• 化学式: C₇H₁₄O
• mdl: MFCD20432300
• 分子量: 114.188
• InChiKey: HIJLVHXVBWTMEV-UHFFFAOYSA-N

物化性质

• 沸点：
  50-51 °C(Press: 20 Torr)
• 密度：
  0.805±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  8
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.857
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-ethylbutyraldehyde 在 镍 盐酸 、 氢气 、 sodium hydride 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 甲醇 、 乙二醇二甲醚 、 乙腈 为溶剂， 65.0 ℃ 、330.95 kPa 条件下， 反应 43.0h， 生成 3-aminomethyl-5-ethylheptanoic acid hydrochloride
  参考文献：
  名称：

  Structure−Activity Relationships of Pregabalin and Analogues That Target the α₂-δ Protein

  摘要：

  Pregabalin exhibits robust activity in preclinical assays indicative of potential antiepileptic, anxiolytic, and antihyperalgesic clinical efficacy. It binds with high affinity to the alpha(2)-delta subunit of voltage-gated calcium channels and is a substrate of the system L neutral amino acid transporter. A series of pregabalin analogues were prepared and evaluated for their alpha(2)-delta binding affinity as demonstrated by their ability to inhibit binding of [H-3]gabapentin to pig brain membranes and for their potency to inhibit the uptake of [H-3]leucine into CHO cells, a measure of their ability to compete with the endogenous substrate at the system L transporter. Compounds were also assessed in vivo for their ability to promote anxiolytic, analgesic, and anticonvulsant actions. These studies suggest that distinct structure activity relationships exist for alpha(2)-delta binding and system L transport inhibition. However, both interactions appear to play an important role in the in vivo profile of these compounds.

  DOI：

  10.1021/jm049762l
• 作为产物：
  描述：

  3-乙基-2-戊烯 在 palladium on activated charcoal 、 (Fe₃O(OAc)6)(C₆H₅N)3.5 2-吡啶甲酸 、 氢气 作用下， 以 水 、 丙酮 为溶剂， 25.0~30.0 ℃ 、6.0 MPa 条件下， 反应 36.0h， 生成 2-ethylbutyraldehyde
  参考文献：
  名称：

  饱和烃的功能化。x.1部分：丙酮和吡啶共溶剂混合物中吡啶中化学和电化学过程（gif和gif-奥赛系统）的比较研究

  摘要：

  六种饱和烃（环己烷，3-乙基戊烷，甲基环戊烷，-和-十氢化萘和金刚烷）被Gif IV系统（铁催化剂，氧气，锌，羧酸）及其电化学当量（Gif-Orsay系统）氧化。对于两种系统，使用各种溶剂（吡啶，丙酮，吡啶-丙酮混合物）获得的结果均相似。用丙酮完全或部分取代吡啶会影响仲位的选择性，并降低酮/仲醇比。由-和-十氢化萘形成相同比例的-和-十氢-9-醇清楚地表明，叔醇是由本质上是自由基的机理产生的。

  DOI：

  10.1016/s0040-4020(01)85889-0

文献信息

• DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE AND PHARMACEUTICALS CONTAINING THE SAME
  申请人：CHUGAI SEIYAKU KABUSHIKI KAISHA

  公开号：US20160002251A1

  公开（公告）日：2016-01-07

  The present invention provides a dihydropyridazine-3,5-dione derivative or a salt thereof, or a solvate of the compound or the salt, a pharmaceutical drug, a pharmaceutical composition, a sodium-dependent phosphate transporter inhibitor, and a preventive and/or therapeutic agent for hyperphosphatemia, secondary hyperparathyroidism, chronic renal failure, chronic kidney disease, and arteriosclerosis associated with vascular calcification comprising the compound as an active ingredient, and a method for prevention and/or treatment.

  本发明提供了一种二氢吡啶嗪-3,5-二酮衍生物或其盐，或化合物或盐的溶剂化合物，一种药物，一种药物组合物，一种钠依赖性磷酸盐转运体抑制剂，以及作为活性成分的化合物的高磷血症、继发性甲状旁腺功能亢进症、慢性肾功能衰竭、慢性肾病和与血管钙化相关的动脉硬化的预防和/或治疗剂，以及预防和/或治疗的方法。
• FUSED HETEROCYCLIC COMPOUND
  申请人：ISHIKAWA Tomoyasu

  公开号：US20090233937A1

  公开（公告）日：2009-09-17

  The present invention provides a fused heterocyclic compound having a tyrosine kinase inhibitory action, which is represented by the formula: wherein ring A is an optionally substituted benzene ring; ring B is an optionally substituted benzoisothiazole ring; R 1 is a hydrogen atom, a halogen atom, or an optionally substituted group bonded via a carbon atom, a nitrogen atom or an oxygen atom; R 2 is a hydrogen atom, or an optionally substituted group bonded via a carbon atom or a sulfur atom; R 3 is a hydrogen atom or an optionally substituted aliphatic hydrocarbon group; or R 1 and R 2 , or R 2 and R 3 are optionally bonded to each other to form an optionally substituted ring structure; or R 3 is optionally bonded to the carbon atom on ring A to form an optionally substituted ring structure; or a salt thereof.

  本发明提供了一种具有酪氨酸激酶抑制作用的融合杂环化合物，其由以下式表示： 其中 环A是一个可选择取代的苯环； 环B是一个可选择取代的苯并异噻唑环； R1是氢原子、卤素原子或通过碳原子、氮原子或氧原子键合的可选择取代基团； R2是氢原子，或通过碳原子或硫原子键合的可选择取代基团； R3是氢原子或可选择取代的脂肪烃基团； 或 R1和R2，或R2和R3可选择键合在一起形成一个可选择取代的环结构； 或 R3可选择键合到环A上的碳原子上形成一个可选择取代的环结构； 或其盐。
• [EN] INSECTICIDAL METHODS USING NITROGEN-CONTAINING HETEROAROMATIC COMPOUNDS<br/>[FR] PROCÉDÉS INSECTICIDES UTILISANT DES COMPOSÉS HÉTÉROAROMATIQUES CONTENANT DE L'AZOTE
  申请人：BASF SE

  公开号：WO2011064188A1

  公开（公告）日：2011-06-03

  Insectical methods using nitrogen containing heteroaromatic compounds The present invention relates to new insecticidal methods of using nitrogen-containing heteroaromatic compounds of the formula (I), wherein A, E, G, M, W, Y, X, R1 and R2 are defined as in the description, and to their enantiomers, diastereomers and agriculturally and veterinary acceptable salts. The present invention relates to methods of administering and applying such Pyridine compounds of formula I for insecticidal use and purposes in agriculture and in the veterinary field. The invention relates also to new derivatives of Pyridine compounds of formula I.

  使用含氮杂芳化合物的杀虫方法。本发明涉及使用式(I)的含氮杂芳化合物的新杀虫方法，其中A、E、G、M、W、Y、X、R1和R2如描述中所定义，并且其对映异构体、顺反异构体和农业和兽医可接受的盐。本发明涉及用于农业和兽医领域的杀虫用途和目的的给药和应用式I的吡啶化合物的方法。该发明还涉及式I的吡啶化合物的新衍生物。
• [EN] INSECTICIDAL METHODS USING PYRIDINE COMPOUNDS<br/>[FR] PROCÉDÉS INSECTICIDES UTILISANT DES COMPOSÉS À BASE DE PYRIDINE
  申请人：BASF SE

  公开号：WO2011057942A1

  公开（公告）日：2011-05-19

  The present invention relates to new insecticidal methods of using compounds of formula (I) wherein A, E, G, M, Y, X, R1 and R2 are defined as in the description, and to their enantiomers, diastereomers and agriculturally and veterinary acceptable salts. The present invention relates to methods of administering and applying such Pyridine compounds of formula I for insecticidal use and purposes in agriculture and in the veterinary field. The invention relates also to new derivatives of Pyridine compounds of formula (I).

  本发明涉及使用式(I)化合物的新杀虫方法，其中A、E、G、M、Y、X、R1和R2的定义如描述中所述，以及它们的对映体、二对映体和农业和兽医可接受的盐。本发明涉及用于杀虫用途和农业以及兽医领域的目的的给药和应用此类吡啶化合物的方法。该发明还涉及式(I)吡啶化合物的新衍生物。
• [EN] SULFONAMIDE COMPOUNDS HAVING TNAP INHIBITORY ACTIVITY<br/>[FR] COMPOSÉS DE SULFONAMIDE AYANT UNE ACTIVITÉ INHIBITRICE DE TNAP
  申请人：DAIICHI SANKYO CO LTD

  公开号：WO2018119444A1

  公开（公告）日：2018-06-28

  The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formula (I) or a pharmacologically acceptable salt thereof.

  本发明涉及一种具有优异的组织非特异性碱性磷酸酶抑制活性的化合物或其药理学上可接受的盐。本发明提供一种由式(I)表示的化合物或其药理学上可接受的盐。